Correlation Between Pasithea Therapeutics and Vincerx Pharma
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Vincerx Pharma, you can compare the effects of market volatilities on Pasithea Therapeutics and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Vincerx Pharma.
Diversification Opportunities for Pasithea Therapeutics and Vincerx Pharma
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pasithea and Vincerx is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Vincerx Pharma go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Vincerx Pharma
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 19.37 times more return on investment than Vincerx Pharma. However, Pasithea Therapeutics is 19.37 times more volatile than Vincerx Pharma. It trades about 0.22 of its potential returns per unit of risk. Vincerx Pharma is currently generating about 0.02 per unit of risk. If you would invest 1.56 in Pasithea Therapeutics Corp on September 12, 2024 and sell it today you would earn a total of 0.94 from holding Pasithea Therapeutics Corp or generate 60.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 52.02% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Vincerx Pharma
Performance |
| Timeline |
| Pasithea Therapeutics |
| Vincerx Pharma |
Pasithea Therapeutics and Vincerx Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Vincerx Pharma
The main advantage of trading using opposite Pasithea Therapeutics and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.The idea behind Pasithea Therapeutics Corp and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |